Guthart Gary S - Oct 30, 2024 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Signature
By: Donna Spinola For: Guthart, Gary S
Stock symbol
ISRG
Transactions as of
Oct 30, 2024
Transactions value $
-$11,593,263
Form type
4
Date filed
10/31/2024, 12:22 PM
Previous filing
Jul 31, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $1.49M +25.2K +146.77% $59.23 42.4K Oct 30, 2024 Direct F1
transaction ISRG Common Stock Sale -$9.29M -18.2K -42.84% $511.63 24.2K Oct 30, 2024 Direct F1, F2
transaction ISRG Common Stock Sale -$1.9M -3.72K -15.74% $510.52 19.9K Oct 30, 2024 Trust FBO Daughter F1, F3
transaction ISRG Common Stock Sale -$1.9M -3.72K -15.74% $510.75 19.9K Oct 30, 2024 Trust FBO Son F1, F4
holding ISRG Common Stock 1.19M Oct 30, 2024 by Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -25.2K -100% $0.00 0 Oct 30, 2024 Common Stock 25.2K $59.23 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 30, 2025.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $508.66 to $516.87 as follows: 1,504 shares sold at $508.66 to $509.50; 8,289 shares sold at $509.67 to $510.63; 3,083 shares sold at $510.68 to $511.54; 775 shares sold at $511.91to $512.30; 599 shares sold at $513.14 to $514.09; 1,728 shares sold at $514.28 to $515.26; 274 shares sold at $515.38 to $515.99; and 1,899 shares sold at $516.56 to $516.87. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $508.51 to $516.31 as follows: 415 shares sold at $508.51 to $509.24; 1,993 shares sold at $509.53 to $510.49; 693 shares sold at $510.54 to $510.93; 320 shares sold at $511.57 to $512.22; 127 shares sold at $512.61 to $512.74; 100 shares sold at $514.47; and 72 shares sold at $516.31. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $508.52 to $516.67 as follows: 388 shares sold at $508.52 to $509.06; 1,698 shares sold at $509.53 to $510.49; 1,155 shares sold at $510.63 to $511.54; 215 shares sold at $511.84 to $512.76; and 264 shares sold at $516.31 to $516.67. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.